This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Robertson MJ, Ritz J . Biology and clinical relevance of human natural killer cells Blood 1990 76: 2421–2438
Cooper MA, Fehniger TA, Caligiuri MA . The biology of human natural killer-cell subsets Trends Immunol 2001 22: 633–640
Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 1999 94: 333–339
Williams NS, Klem J, Puzanov IJ, Sivakumar PV, Schatzle JD, Bennett M, Kumar V . Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems Immunol Rev 1998 165: 47–61
Fehniger TA, Caligiuri MA . Interleukin 15: biology and relevance to human disease Blood 2001 97: 14–32
Mrozek E, Anderson P, Caligiuri MA . Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells Blood 1996 87: 2632–2640
Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA . Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15 Blood 1998 92: 3647–3657
Fehniger TA, Carson WE, Mrozek E, Caligiuri MA . Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo Blood 1997 90: 3647–3653
Baer MR, Pixley LA, Schriber JR, Frankel SR, Fehniger TA, Herzig GP, Caligiuri MA . Prolonged administration of low-dose interleukin-2 (IL-2) to patients (PTS) with acute myeloid leukemia (AML) in remission (CR) expands natural killer (NK) cells without significant clinical toxicity Blood 1998 92 (Suppl. 1): 2534 (Abstr)
Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 1986 136: 4480–4486
Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J . Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors J Exp Med 1990 171: 1509–1526
Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA . Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset Blood 2001 97: 3146–3151
Lanier LL . On guard – activating NK cell receptors Nat Immunol 2001 2: 23–27
Moretta A, Bottino C, Vitale M et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 2001 19: 197–223
Groh V, Steinle A, Bauer S, Spies T . Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells Science 1998 279: 1737–1740
Pende D, Cantoni C, Rivera P et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin Eur J Immunol 2001 31: 1076–1086
Author information
Authors and Affiliations
Additional information
This paper is part of a series of keynote addresses to be published in Leukemia. They were presented at the Acute Leukemia Forum, San Francisco, 20 April 2001. Supported by an unrestricted educational grant from Immunex.
Rights and permissions
About this article
Cite this article
Cooper, M., Caligiuri, M. Immunologic manipulation in AML: from bench to bedside. Leukemia 16, 736–737 (2002). https://doi.org/10.1038/sj.leu.2402411
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402411